# Trial to Demonstrate the Safety and Effectiveness of the MiStent II for the Revascularization of Coronary Arteries.

> **NCT03423511** · NA · NOT_YET_RECRUITING · sponsor: **Micell Technologies** · enrollment: 1300 (estimated)

## Conditions studied

- Coronary Artery Disease

## Interventions

- **DEVICE:** MiStent II coronary artery stent
- **DEVICE:** Xience or Promus coronary artery stents

## Key facts

- **NCT ID:** NCT03423511
- **Lead sponsor:** Micell Technologies
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2021-12-31
- **Primary completion:** 2023-06-01
- **Final completion:** 2027-06-01
- **Target enrollment:** 1300 (ESTIMATED)
- **Last updated:** 2020-09-04

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03423511

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03423511, "Trial to Demonstrate the Safety and Effectiveness of the MiStent II for the Revascularization of Coronary Arteries.". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT03423511. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*